from
Precision Clinical Intelligence Ltd
MAb evolution becomes treatment revolution
What is MABVIEWER?
MABVIEWER is a revolutionary Software-as-a-Medical Device platform that combines existing molecular imaging technology with our patented algorithms to quantify patient response to a monoclonal antibody. Potential applications include:
Monoclonal antibody selection
MABVIEWER guides monoclonal antibody selection to improve patient outcomes.
Informing clinical trial design
MABVIEWER informs clinical trial design through identification of responder populations.
Inflammatory phenotyping
MABVIEWER delivers a step change in inflammatory phenotyping for novel target identification and validation.
A molecular imaging approach to precision medicine
MABVIEWER leverages existing molecular imaging technology, combined with our AI-enhanced algorithms to deliver a revolutionary approach to precision medicine.
The MABVIEWER platform
Bringing molecular imaging to the clinic
MABVIEWER overcomes the complexity usually associated with molecular imaging, allowing the full potential of this technique to be realised, delivering real value to physicians and patients.
Cloud-based architecture
MABVIEWER will utilise a fully cloud-based architecture, enabling us to deliver value to physicians and patients on a global scale.
The Team
A short video introduction to MABVIEWER from Professor Tom Wilkinson, co-founder of Precision Clinical Intelligence Ltd.
An introduction to the MABVIEWER technology from Dr Michael Bennett,
co-founder of Precision Clinical Intelligence Ltd.
Contact Us
If you would like to know more about MABVIEWER, then please get in touch using the form below.